
New research indicates that even with effective antiretroviral treatment, HIV may still affect the central nervous system.

New research indicates that even with effective antiretroviral treatment, HIV may still affect the central nervous system.

According to a press release, this is the first single-agent, anti-PD-1 therapy approved in the first-line environment for this patient population.

OnScript is dedicated to providing the pharmacy technician workforce with news, real life stories and discussions that can impact personal and professional growth.

The findings include airway inflammation and rapid development of pulmonary edema, coronary artery aneurysms, and extensive intra-abdominal inflammatory changes, according to the study authors.

A recent study showed that long-term exposure to fine particulate outdoor air pollution is a key contributor to cardiovascular disease and death throughout the world, regardless of the income bracket of the various countries.

Collaboration between pharmacists and general practice teams improves patient care and increases savings.

A new heart valve combines the biocompatibility of a biological valve with the robustness of a mechanical one.

Erlotinib taken with gemcitabine was approved by the FDA for locally advanced, inoperable, or metastatic pancreatic cancer in 2005.

According to the FDA, patients should be selected based on an FDA-approved companion diagnostic test.

Remdesivir, the investigational drug for the treatment of the coronavirus disease 2019 (COVID-19), will be sold for $390 per vial.

Some states are implementing laws that are allowing pharmacists to expand their roles temporarily, but these laws vary by state and there is no uniformity in what all pharmacists can do during this time.

COVID-19 attacks the cardiovascular system and may exasperate preexisting heart conditions.

How could a patient be having a heart attack if the troponin levels were super low?

The dipeptide used in the study is the only known amino acid to make the trip from a mouse’s stomach to its brain intact, according to the study authors.

Current research has already found that CVD is among the most common pre-existing conditions among people who die from COVID-19.

A new study found disturbing evidence that black cancer survivors are more likely to face financial hardship on high deductible health plans than their white counterparts.

Organ transplants from seropositive donors carry a high risk of infection from the transplanted organ.

Pharmacists can play an important role in educating pregnant patients along with individuals planning to become pregnant about COVID-19 prevention strategies and tips to stay healthy during the pandemic.

The paper is an update to previous guidelines released by ACSM and the American Heart Association in 1998.

Studying blood samples from critically ill patients at the London Health Sciences Center (LHSC), the researchers identified a unique pattern of 6 molecules that could be used as therapeutic targets to treat the virus, as reported in the Critical Care Explorations journal.

Dravet syndrome is a life-threatening, rare, and chronic form of epilepsy and is often characterized by severe, unrelenting seizures despite medical treatment, according to the FDA press release.

The measles, mumps, and rubella vaccine may hold the key to the mystery surrounding children and the COVID-19 pandemic.

The pharmaceutical industry is already seeing the immense benefit of AI and machine-learning technology.

Top news of the week from Pharmacy Times®.

What is the resource Approved Drug Products With Therapeutic Equivalence Evaluations commonly called?

Data from a new analysis reinforces concerns surrounding the detrimental impact the novel osteoporotic therapy romosozumab can have on cardiovascular health.

Many companies are working with health systems to transition patients from the hospital to in-home care as quickly as possible.

Pembrolizumab has been approved by the FDA as a monotherapy for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma.

According to the survey results, not only do a majority of the 500 respondents experience fear of bleeding events, but many of them also avoid or modify activities in order to mitigate their risk.

According to the investigators, payers and employers are increasingly adopting HDHPs in an effort to control rising health care costs.